Altamira Therapeutics Ltd. Increase Decrease Through Exercise Of Warrants Equity
Altamira Therapeutics Ltd. (CYTOF) reported Increase Decrease Through Exercise Of Warrants Equity of $2.64 million for the 6-month period ending 2024-06-30, per its 6-K filed 2024-09-24.
Discontinued › Notes
ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity · last filed 2024-09-24
CHF
| Period end | Increase Decrease Through Exercise Of Warrants Equity 12 month |
|---|---|
| 2023-12-31 | 5.52M CHF 20-F/A · filed 2024-04-22 |
| 2022-12-31 | 4.23M CHF 20-F/A · filed 2024-04-22 |
| 2021-12-31 | 7.10M CHF 20-F/A · filed 2024-04-22 |
USD
| Period end | Increase Decrease Through Exercise Of Warrants Equity 6 month |
|---|---|
| 2024-06-30 | $2.64M 6-K · filed 2024-09-24 |
| 2023-06-30 | $6.03M 6-K · filed 2024-09-24 |